Schizophrenia Trial, Recruiting NCT07446478 Sponsor: Central South University Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07446478
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 50 years old
  • People who have been diagnosed with schizophrenia according to standard medical guidelines (DSM-5), confirmed through a structured clinical interview
  • People whose schizophrenia was diagnosed no more than 8 years ago
  • People who are currently taking 1 or 2 antipsychotic medications, with the dose having been stable for at least 1 week before joining the trial (certain other medications, such as mood stabilisers, antidepressants, or higher doses of some sedatives, are not permitted)
  • People whose antipsychotic medication type stays the same during the trial, with any dose changes kept within 25%
  • People who have difficulty with day-to-day activities and functioning
  • People who show a certain level of cognitive (thinking and memory) difficulties, as measured by a specific assessment tool called the MCCB (confirm with trial site for exact score requirements)
  • People who are willing to take part and have signed a written consent form

Who may not be able to join:

  • People who have other mental health conditions, intellectual disability, significant mood symptoms, or problems with substance use (other than caffeine or tobacco)
  • People who are experiencing clear movement-related side effects caused by their medication (known as drug-induced extrapyramidal reactions)
  • People with a history of epileptic seizures, meningitis, or encephalitis (brain inflammation or infection)
  • People for whom brain stimulation through the scalp (transcranial electrical stimulation) would not be medically safe
  • People with a history of brain tumours or brain surgery
  • People who have had a severe head injury in the past
  • People who have received any other electrical or magnetic brain therapy within the month before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 15874179855

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Central South University
Registry
ClinicalTrials.gov
Start date
24 June 2026
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

changes on MCCB scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov